Showing results (341-350 of 379) with videos related to
Sort By:
Pageof 38
Proceedings of the National Academy of Sciences of the United States of America|September 11, 2020
Suboptimal SARS-CoV-2-specific CD8+ T cell response associated with the prominent HLA-A*02:01 phenotypeJennifer R Habel, Thi H O Nguyen, Carolien E van de Sandt, et al.Journal of Global Antimicrobial Resistance|June 23, 2022
Attributable mortality and excess length of stay associated with third-generation cephalosporin-resistant Enterobacterales bloodstream infections: a prospective cohort study in Suva, FijiMichael J Loftus, Tracey E M W Young-Sharma, Sue J Lee, et al.Clinical & Translational Immunology|March 8, 2021
Robust correlations across six SARS-CoV-2 serology assays detecting distinct antibody featuresLouise C Rowntree, Brendon Y Chua, Suellen Nicholson, et al.NPJ Precision Oncology|June 8, 2024
Artificial intelligence-based epigenomic, transcriptomic and histologic signatures of tobacco use in oral squamous cell carcinomaChi T Viet, Kesava R Asam, Gary Yu, et al.Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 14, 2019
Heterogeneity in influenza seasonality and vaccine effectiveness in Australia, Chile, New Zealand and South Africa: early estimates of the 2019 influenza seasonSheena G Sullivan, Carmen S Arriola, Judy Bocacao, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|July 15, 2020
Search and Contain: Impact of an Integrated Genomic and Epidemiological Surveillance and Response Program for Control of Carbapenemase-producing EnterobacteralesCourtney R Lane, Judith Brett, Mark Schultz, et al.Vaccine|October 30, 2023
Superior immunogenicity of mRNA over adenoviral vectored COVID-19 vaccines reflects B cell dynamics independent of anti-vector immunity: Implications for future pandemic vaccinesYi Liu, Stephany Sánchez-Ovando, Louise Carolan, et al.Nature Medicine|May 14, 2020
A serological assay to detect SARS-CoV-2 seroconversion in humansFatima Amanat, Daniel Stadlbauer, Shirin Strohmeier, et al.The Lancet. Microbe|May 11, 2022
A controlled human infection model of Streptococcus pyogenes pharyngitis (CHIVAS-M75): an observational, dose-finding studyJoshua Osowicki, Kristy I Azzopardi, Loraine Fabri, et al.Nature Communications|February 28, 2018
Clonally diverse CD38+HLA-DR+CD8+ T cells persist during fatal H7N9 diseaseZhongfang Wang, Lingyan Zhu, Thi H O Nguyen, et al.Pageof 38